Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abcellera, Altimmune, Amphastar, Anixa, Applied DNA Sciences, Asieris, Beigene, Beijing Youfeng Biological Technology, Biontech, CSL Behring, Cytodyn, Effector, Esteve, Evvivax, Fortress, Fuji Yakuhin, Generex, Hcmed Innovations, Hoth, Hutchmed, Ibio, Inspira, ITM, Kowa, Lupin, Moderna, Molecular Partners, Molgenie, Nabriva Therapeutics Ireland, Nexturn, Nicox, Novavax, Ocugen, Olix, Ontochem, PCI, Pharmabcine, Recce, Roivant Sciences, Rosvivo, Samsung Bioepis, Sumitomo Dainippon, Takanawa Japan, Tiziana Life Sciences, Trevena, Vectura, Wuxi Biologics, Yiling.